Corbus poaches Takeda's oncology leader as it beefs up early-stage pipeline following three trial failures

With multiple mid- and late-stage failures of its only clinical-stage compound, Corbus Pharmaceuticals is attempting to move forward with earlier-stage assets it in-licensed this summer. So the biopharma hired Takeda oncology leader Rachael Brake as chief scientific officer to lead those efforts.

Related Keywords

California ,United States ,San Francisco , ,University Of California ,Amgen ,Panorama Research ,Corbus Pharmaceuticals ,Millennium Pharmaceuticals ,Rachael Brake ,Japanese Big Pharma ,Corbus ,Makeda ,Chief Scientific Officer ,Chutes And Ladders ,Lupus ,Sclerosis Drug ,Cystic Fibrosis ,